Melatonin was found to improve pancreatic organ function in diseased animals. To study whether pancreatic bicarbonate secretion is stimulated by melatonin, investigations were done in two human ductal pancreatic adenocarcinoma cell lines MIA PaCa-2 (MIA) and PANC-1 (PANC). Using the fluorescence pH-sensor BCECF-AM, we monitored melatonin effects on basal intracellular pH (pH i ), and on pH i recovery after intracellular alkalinization produced by the removal of extracellular HCO 3 -/CO 2 . Exposure to 1µM melatonin for 24hrs and presence of the indoleamine during the experiment increases the basal pH i . Moreover, pH i recovery and HCO 3 -secretion are facilitated after the alkaline load. These findings are in line with the observed increase in mRNA expression of the Na exchanger SLC9A1 mRNA would favor pH i recovery after alkalinization, but it does not explain the initial increase in pH i . This controversial effect and the requirement for continuous presence of melatonin throughout the experiment suggest that nontranscriptional signalling may contribute to the effects of melatonin on acid/base movements. In summary, we show a stimulatory effect of melatonin on bicarbonate secretion in the pancreatic cancer cell lines which may help to prevent duodenal damage.
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Introduction
Melatonin, originally thought to be produced and secreted exclusively by the pineal gland, is present in the gastrointestinal tract at high concentrations, which, during daytime, exceed serum levels by 10 to 100-fold [1, 2] . Gastrointestinal melatonin is partly taken up from the circulation, but a large amount of melatonin itself or its 92 precursors serotonin and tryptophan are derived from dietary sources [3, 4] . Expression of the two melatonin synthesizing enzymes, arylalkylamine N-acetyltransferase (AANAT) and hydroxyindole-O-methyltransferase (HIOMT) was detected in various gastrointestinal organs including pancreas, although pancreatic melatonin synthesis has not been proven so far [5] .
Melatonin was suggested to have beneficial effects in various gastrointestinal organs. In the stomach, melatonin was found to inhibit acid secretion [6, 7] , and it induces duodenal HCO 3 - secretion in response to gastric acid [8] . Studies in animals showed that melatonin stimulates pancreatic enzyme secretion and improves the outcome of experimental pancreatitis [9] [10] [11] . Favorable effects of melatonin on pancreatic function have been related to its antioxidative effects [12] [13] [14] and, in line with findings in other gastrointestinal organs, its ability to regulate ion transport and to stimulate epithelial regeneration might contribute [15] .
Quantitatively, the pancreatic duct epithelium has the highest HCO 3 - secretion capacity with concentrations reaching up to 150 mM HCO 3 - in the pancreatic fluid. This efficient secretion of HCO 3 - is essential to neutralize the acidic chyme and dissolve secreted enzymes thereby preventing duodenal ulcera [16] .
Transcellular transport of membrane impermeable HCO 3 - is facilitated by integral membrane transport proteins, such as members of the SLC family. In the pancreatic ductal epithelial cells, HCO 3 - secretion is dependent on the basolateral Na + /HCO 3 -cotransporter (SLC4A4b) [17] , through which HCO 3 -enters the cells from the blood, and on the uptake of CO 2 , which directly permeates into the cell interior, where it is rapidly converted into HCO 3 exchangers from the SLC26A family, namely the SLC26A6 and SLC26A3 [19] . SLC26A6 has a major role in luminal HCO 3 -secretion and it is proposed that this exchanger is stimulated by the activity of the ATP-binding cassette transporter ABCC7, the cystic fibrosis transmembrane conductance regulator CFTR [20] .
Analogous to its stimulatory effect on bicarbonate secretion in the duodenum [21] , we are interested whether melatonin enhances HCO 3 -secretion in pancreatic ducts as well. It is also remarkable to note that melatonin was found to alter membrane transport properties in other cells as well. For example, in kidney cells, melatonin modulates water movements by stimulation of Na + /K + ATPase activity via a mechanism involving actin binding [22, 23] .
To stimulate pancreatic bicarbonate secretion, melatonin could modulate solute transporter activity and/ or alter their expression. For this purpose, the indoleamine might act through binding and activation of its G-protein coupled melatonin receptors MT1 and MT2 or in a receptor independent way [24] [25] [26] [27] . At the molecular level, activation of MT1 and MT2 inhibits forskolin-stimulated cAMP formation via a pertussis toxin sensitive G i protein in various cells and tissues. On the other hand, stimulation of cAMP synthesis via a Ca ++ -calmodulin dependent pathway requiring MT1 activation [28] or being independent on the G-protein coupled receptors [29] had been found in different cell lines under certain conditions. Additionally, melatonin was found to modulate gene transcription via nuclear receptors, e.g. through retinoid orphan receptor (ROR) α activation [30] . While receptor activation requires nanomolar concentrations of the indoleamine, at micromolar concentrations, melatonin is a powerful antioxidant [31] . Such high concentrations were found to be reached, e.g. in lymphocytes [32] . It acts as a direct scavenger of free radicals and it also acts in a non-scavenging way. For example, it activates and induces the expression of antioxidative enzymes and inhibits prooxidant enzymes, e.g. nitric oxide synthase [31, 33] .
Through these different mechanisms, melatonin could improve the function of the exocrine pancreas. In any case, by influencing ion homeostasis and inducing pancreatic bicarbonate secretion, together, with its direct stimulating effect on duodenal alkaline secretion [8] , melatonin could offer a powerful protection against acidinduced ulcers in the duodenum.
These considerations prompted us to study the influence of melatonin on basal intracellular pH (pH i ), and on the rate of HCO 3 -secretion in two pancreatic carcinoma cell lines, namely MIA PaCa-2 (MIA) and PANC-1 (PANC) cells, both, derived from human ductal pancreatic adenocarcinomas. These cell lines offer a good model for the investigation of melatonin effects on acid/ base movements, as they express different amounts of solute transporters SLC4A4b and SLC26A6 for bicarbonate uptake and secretion, respectively, as well as the Na 
Materials and Methods
Materials N-2-hydroxyethylpiperazine-N´-2-ethanesulfonic acid (HEPES), dimethyl sulfoxide (DMSO), nigericin, choline chloride, forskolin, tetramethylammonium hydroxide (TMA-OH), melatonin, gluconic acid, 2´7´-bis(2-carboxyethyl)-5(6)-carboxyfluorescein-acetoxymethylester (BCECF-AM), bisbenzimide, saponin, Tris(hydroxymethyl)aminomethane (TRIS), ethylenediaminetetraacetic acid (EDTA), ethyleneglycoltetraacetic acid (EGTA), dithiothreitol (DTT), phenylmethylsulphonyl fluoride (PMSF), Nonidet NP-40, and a combined phosphatase/protease inhibitor cocktail were purchased from Sigma (St. Louis, MO). All other chemicals were from Merck (Darmstadt, Germany). RPMI 1640 cell culture medium without phenol red, penicillin/streptomycin and charcoal-treated fetal bovine serum (FBS) were from PAN Biotech (Aldenbach, Germany). Fetal bovine serum (FBS) and trypsin/EDTA were from GIBCO, Invitrogen Corp. (Grand Island, NY).
Cell culture MIA PaCa-2 (ATCC CRL 1420) and PANC-1 (ATCC CRL 1469) cells were originally obtained from the American Type Culture Collection (ATCC, Rockville, MD). Both cell lines were maintained in RPMI 1640 tissue culture medium without phenolred supplemented with 10% FBS, penicillin (100 U/ml), and streptomycin (0.1 mg/ml). Cells were cultivated under standard conditions at 37°C in a humidified atmosphere containing 5% CO 2 and 95% air. Media were changed every second day and cells were passaged by trypsinization twice a week. For isolation of total RNA, cells were treated with 1µM melatonin (1 mM stock in DMSO) for 24 h in RPMI 1640 medium supplemented with 2.5% charcoal treated FBS and antibiotics. For intracellular pH measurements, two days before the experiment, cells were transferred to 6-well plates and grown on glass coverslips. 24 h before the measurements, cells were treated with 1, 0.5 and 0.1 µM melatonin, respectively. Control experiments were performed with the vehicle only (0.1% DMSO).
Buffers for pH experiments
Bicarbonate-free bath solution contained (mM): NaCl 135, KCl 4.7, MgSO 4 1, KH 2 PO 4 1.2, CaCl 2 1.5, HEPES 10, glucose 5, titrated to pH 7.4 at 37°C with NaOH. In the bicarbonate buffered solution, HEPES was replaced by 25 mM NaHCO 3 and equilibrated with 5% CO 2 at 37°C.
Intracellular pH (pH i ) measurements
Intracellular pH was measured using the fluorescent intracellular sensor BCECF [34] . In brief, BCECF was loaded into cells in the form of its tetraacetoxymethylester derivative (BCECF-AM) (12 µM) by incubation for 10-20 min at 37°C. After washing for 10 min at 37°C in the BCECF-free bicarbonate solution, the cell containing glass coverslips were transferred into a thermostated (37°C) perfusion chamber placed on the stage of an Axiovert (Zeiss, Jena, Germany) inverted microscope. The microscope was equipped with a microfluorometer (Photon Technology Instruments, Monmouth Junction, NJ) for continuous dual wavelength excitation photometry.
Intracellular pH was measured in single cells as the ratio of emission intensities at 530 nm after excitation at 495 nm (pH i and concentration sensitive) and 440 nm (only concentration sensitive), respectively. Data were collected at 50 Hz chopping frequency and averaged every 2 sec. After each experiment, internal dye calibration was performed by superfusing the cells with nigericin (12 µM) at pH 6.8 and 7.6, respectively.
Measurements of pH recovery rate after bicarbonate load
Cells were first superfused for 60 sec with a 25mM HCO 3 -, 5% CO 2 containing solution, which results in intracellular equilibration of HCO 3 - according to pH i . Acute removal of CO 2 / HCO 3 -from the superfusion medium by switching to the HEPES-buffered bicarbonate-free solution, results in a sudden depletion of intracellular CO 2 and intracellular alkalinization. Thereafter, intracellular pH recovers from this alkaline load towards the initial value by HCO 3 -extrusion [35] .
Data analysis and statistics
To avoid systematic errors in comparing one experimental condition with control, we performed the respective experiments on the same day, from one set of cell cultures. Data were acquired from single cells. They are given as mean values ± SD (n=number of experiments). δpH/δt = U/min (sec 100 -sec 160). Differences between grouped experiments are evaluated by the one-tailed unpaired Students t-test. β-actin served as an endogenous control. For negative controls, the PCR reaction was performed without a template or with RNA prior to reverse transcription. Amplified cDNA was visualized by ethidium bromide staining on 2% agarose gels on a Herolab gelscanner (Wiesbach, Germany).
Conventional and quantitative real-time RT-PCR
For relative quantitation of MT1 and MT2 mRNA, respectively, gene-specific oligonucleotide primer pairs and oligonucleotide probes, respectively, labeled with 6-carboxyfluorescein (FAM) and the quencher 6-carboxytetramethylrhodamine (TAMRA), were designed using the Primer Express Software (National Bioscience, Plymouth, MN). The following primers and probes were applied: MT1 forward: 5´-CGG TGT ATC GGA ACA AGA AGC T-3´,  MT1 reverse: 5´-AGG TCT GCC ACC GCT AAG C-3´, MT1  probe: 6-FAM-TCA CCA CAA AGA TGT TTC CTG CGT TCC  T-TAMRA; MT2 forward: 5´-TGC TCA GGA ACC GCA AGC-3´, MT2 reverse: 5´-AGG TCA GCC AAT GCC AGA CT-3´, MT2 probe: 6-FAM-ACC AAG AAC AAA TTA CCT GCG TTC CGG-TAMRA. For relative quantitation of pancreatic solute transporters, TaqMan® Gene Expression Assays (Applied Biosystems, AB, Foster City, CA) were applied: SLC26A6: Hs00370470_m1, SLC4A4: Hs00186798_m1, SLC9A1: Hs00384604_m1. All mRNA levels were normalized to ribosomal 18S expression. The PCR reactions were performed on the ABI PRISM 7700 Sequence Detector (AB). Respective mRNA levels were calculated using the relative standard curve method (AB, User Bulletin 2).
Treatments with either melatonin or the solvent (0.1% DMSO) were performed for each cell line and RNAs were isolated and reverse transcribed. Subsequent PCRs were performed in triplicates. For quantitative PCR, four plates, in which samples were done at least in triplicates, were independently analyzed for each target. Differences were evaluated by an unpaired Student´s t-test. Differences are considered significant if p<0.05.
Measurement of total cellular cAMP 96-well plates containing 2x10
4 cells/well were first pretreated for 24 hrs with 2.5% charcoal stripped FBS in RPMI 1640 medium, before 1 µM melatonin was added for 5 min and 24 hrs, respectively. The subsequent cell lysis and the enzyme immunoassay (EIA) were performed using the cAMP Biotrak EIA System (Amersham Biosciences UK Ltd, Buckinghamshire, UK). In brief, following the addition of the lysis reagent, a microscopic evaluation of cell lysis was done with Trypan blue. Thereafter, 100 µl aliquots were transferred to the antibody coated 96-well plate for the assay. Preparation of working standards and the assay procedure were carried out according to the manufacturers´ protocol and the optical density was determined at 450 nm within 30 min. Experiments were done in triplicates.
Results

Effects of melatonin on pH i in MIA PaCa-2 (MIA) and PANC-1 (PANC) cells
For the evaluation of melatonin effects on pH i , MIA and PANC cells were treated with 1 µM of the hormone under different experimental conditions (3 groups). In the MEL group, cells were exposed to melatonin during the pH measurement. Cells from the inc group were pretreated with melatonin for 24 hrs, but the hormone was absent during measurements. In the MEL/inc group, cells were both, preincubated and exposed to melatonin throughout the experiment.
As demonstrated in Fig. 1 (A-D) , in absence of melatonin (control), the basal pH i in MIA was 7.16 ± 0.03 and in PANC cells 7.1 ± 0.06. To study the effect of melatonin on bicarbonate secretion, NaHCO 3 was replaced by HEPES in the external buffer and CO 2 was omitted. This caused a rapid increase in the pH i by 0.24 units (to 7.40 ± 0.04) in MIA and by 0.39 units (to 7.49 ± 0.07) in PANC cells. During the following stimulation of bicarbonate extrusion, the recovery rate of pH i in MIA was slower (δpH/δt = -0.064 ± 0.012 /min) than in PANC cells (δpH/δt = -0.09 ± 0.04 /min).
As shown in Fig. 1 , A-D, melatonin shifted basal pH i towards a more alkaline value. This change in basal pH i was significant, if MIA and PANC cells were both, pretreated for 24 hrs with the hormone and exposed to 1µM melatonin during measurements (MEL/inc). The increase of pH i was more pronounced in MIA cells, in which pH i rose to 7.34 ± 0.07 (p <0.01 vs. control), while in PANC cells, pH i rose to 7.21 ± 0.07 (p <0.05 vs. control).
In MEL/inc treated cells, the rate of recovery of pH i after an alkaline load was increased. In MIA cells, the rate was strongly accelerated from δpH/δt -0.064 ± 0.012 to δpH/δt -0.09 ± 0.02 (p <0.01), while in PANC cells, the increase in the rate was not significant (δpH/δt -0.09 ± 0.04 to δpH/δt -0. 11 ± 0.04, n.s. (Fig. 1,C,D) .
Remarkably, under both, MEL and inc conditions, the basal pH i and the recovery rate after alkaline load were not significantly altered in MIA (Fig. 1A) and in PANC cells (Fig. 1B) To gain insight into the contribution of individual transporters, ion substitution studies were done, in which in the extracellular medium, i) Na + was replaced by choline and ii) Cl -by gluconate (Fig. 1 E,F) . i) In the absence of extracellular Na + , the basal pH was lower as compared to MEL/inc data in presence of Na + (7.08 ± 0.03 vs. 7.34 ± 0.07; p<0.05 in MIA and 7.01 ± 0.01 vs. 7.21 ± 0.07; p<0.05 in PANC). It was comparable to the more acidic pH i values in untreated (Fig. 1C,D) , in which the initial pH i was 7.34 ± 0.07 in MIA MEL/inc and 7.21 ± 0.07 in PANC MEL/ inc. The lack of Cl -dependence makes it unlikely that the melatonin effect on the initial pH i is caused by reduced activity of the Cl Studies were done with two additional melatonin doses (0.1 and 0.5 µM) to establish a dose dependency for the effect of MEL/inc treatment on intracellular pH regulation (Table 1) . These studies were carried out in MIA cells, in which significant effects on pH i regulation were observed for MEL/inc (1 µM) treatment. Although 0.1 and 0.5 µM melatonin had a tendency to stimulate pH i recovery after bicarbonate load, these effects did not reach the level of significance.
Influence of melatonin on the mRNA expression of pancreatic solute transporters SLC26A6, SLC4A4b, SLC9A1
As assessed by conventional PCR, substantial amounts of mRNA of the solute transporters SLC26A6 and SLC9A1 are expressed in MIA and PANC cells, while SLC4A4b mRNA is near the detection limit in MIA cells (Fig. 2) . Quantitative PCR revealed that the mRNA expression levels of SLC26A6 and SLC9A1 are comparable in MIA and in PANC cells, while SLC4A4b mRNA levels are 6-fold higher in PANC cells (p<0.05) (Fig. 2) .
Treatment with 1 µM melatonin for 24 hrs (MEL) increased mRNA expression of the HCO 3 -transporters SLC26A6 and SLC4A4b in MIA cells. However, it reduced the Na + /H + exchanger SLC9A1 mRNA. Quantitative PCR revealed a 2.2 (p<0.01) and a 2.3-fold (p<0.05) increase of SLC26A6 and SLC4A4b mRNA, respectively in MIA cells. In contrast, a 40% reduction of SLC9A1 mRNA was observed in both cell lines (p<0.05).
Both, conventional and quantitative PCR revealed that the second Cl -/HCO 3 -transporter, namely SLC26A3, which is expressed in the apical membrane of normal pancreatic ductal epithelial cells [38] is near the detection limit in the two cell lines. Additionally, the splice variant SLC4A4a, also present in normal pancreatic tissue [17] , is not detectable in these cells (data not shown). Therefore, no further studies on these transporters were done.
Melatonin inhibits forskolin induced cAMP formation in MIA and PANC cell lines
As previous studies showed that ion movements in pancreatic duct cells are coupled to cAMP/PKA activation, we investigated whether melatonin might alter cAMP levels in the pancreatic carcinoma cell lines (Fig.  3) . We applied 1 µM melatonin, as this dose was effective to alter solute movements in these cell lines. As assessed by an enzyme immunoassay (EIA), basal cAMP levels were 2-fold higher in PANC than in MIA cells and were not affected by short (5 min) and long (24 hrs) term treatment with melatonin. However, melatonin reduced forskolin-induced formation of cAMP, an effect which was previously described to be mediated via activation of G-protein coupled melatonin receptors MT1/MT2 [25] . After 24 hrs of treatment with 1 µM forskolin, cAMP was increased by 3.7-fold in MIA and 2.6-fold in PANC cells. Incubation with 1 µM melatonin for 24 hrs significantly reduced the forskolin-stimulated increase in intracellular cAMP in both cell lines (by 50% and 30 % in MIA and PANC cells, respectively, p<0.05).
Further RT-PCR studies showed that both cell lines express MT1, but not MT2 mRNA (Fig. 4A) and protein (Fig. 4B) . Higher MT1 mRNA levels were observed in less sensitive PANC cells (11.9 ± 2.34-fold higher in PANC In humans, melatonin is frequently applied as an "over the counter drug" against disorders like jet leg, insomnia, seasonal depression [39] and it is used in alternative cancer therapy [40] . For the latter, doses as high as 80 mg are given and serum melatonin concentrations up to 10.000-fold higher than the usual night time peak concentration of 0.26 nM were reported [41] . In that case, serum concentrations of approx. 1 µM, which correspond to the melatonin dose effective in the two pancreatic cancer cell lines, could be expected.
Using the pH i sensor BCECF-AM, we demonstrate that, particularly in MIA cells, melatonin increases basal pH i and, after an alkaline load, it stimulates base extrusion, thereby accelerating the recovery of pH i to initial values in melatonin pretreated cells in the presence of the indoleamine. Under these conditions, an increase in mRNA expression of SLC4A4b for HCO 3 - Moreover, the correlation appears to be quantitative in that the twofold higher induction of SLC4A4b and SLC26A6 mRNA in MIA as compared to PANC cells is linked to the more pronounced effects of the hormone on basal pH i and on HCO 3 -secretion in the former cell line. Not entirely concordant with these observations, we found that expression of the Na + /H + exchanger SLC9A1 mRNA is reduced by melatonin, which, at the functional level, would be expected to acidify initial basal pH i . If melatonin affects acid/base movements only through altered transporter expression, an initial intracellular acidification caused by decreased expression of SLC9A1 would be expected. Otherwise, enhanced bicarbonate influx via the increased SLC4A4b should counteract this acidification. However, this does not seem to be sufficient, as the observed rise in initial pH i requires the presence of melatonin in addition to melatonin pretreatment. This suggests that melatonin has additional non-genomic effects on acid/ base transport as well.
On the other hand, reduced expression of SLC9A1 mRNA would facilitate pH i recovery to initial values after alkaline load produced by removal of extracellular HCO 3 -/CO 2 . Therefore, melatonin seems to have different effects on SLC9A1. In fact, recent data from studies in mouse pancreatic acinar cells revealed that SLC9A1 activity is coupled to the function of the intracellular carbonic anhydrase [42] , which vice versa, depends on the concentration of HCO 3 -/CO 2 in the extracellular medium [43] . Through altered activity of this enzyme, divergent effects of melatonin on SLC9A1 activity in the absence and presence of HCO 3 -/CO 2 might be explained. [35] . This is concordant with our data, which show that the recovery is sensitive to the removal of Cl -. In line with these findings, alterations in intracellular Ca ++ by melatonin were reported to increase HCO 3 -secretion in isolated duodenal enterocytes. In these cells, melatonin induced the release of Ca ++ from intracellular stores and stimulated Ca ++ influx [44] . Although this was attributed to MT2 activation in enterocytes, we can exclude involvement of MT2 on the observed acid/base movements in both pancreatic cancer cell lines, as MT1 was the only MT isoform detectable in MIA and PANC cells. However, the following observations suggest that MT1 is unlikely to modulate acid/base transport in these cell lines: i) The effective dose of 1 µM to modulate ion movements in the pancreatic cancer cell lines is clearly above the Kd of 30-160 pM for 125 I-iodomelatonin and 1 nM melatonin for MT1 activation [45] . ii) MT1 expression levels are lower in MIA than in PANC cells, while melatonin effects on ion transport are more pronounced in MIA cells. iii) Treatment with 1 µM melatonin for 24 hrs down-regulates MT1 expression, which would diminish the effectiveness of MT1 mediated signaling. This is in accordance with data from MT1 overexpressing CHO cells, in which longer exposure to the hormone not only caused a downregulation of the receptor but also decreased the affinity for the hormone [27] . iv) In both cell lines, we found that melatonin inhibits forskolin-induced cAMP formation. Since it has previously been shown that in PANC cells, the forskolin-induced cAMP formation stimulates HCO 3 -extrusion [35] , inhibition of cAMP formation, as observed in this study, should rather inhibit HCO 3 -secretion. Because the opposite is true in our studies, we thus conclude that cAMP signalling is not a means of altering ion transport activities in the pancreatic cancer cell lines.
Taken together, our data on the melatonin-induced stimulation of bicarbonate secretion in the two pancreatic cancer cell lines provide the first evidence for a transcriptional effect of melatonin on ion transport proteins although non-genomic effects also contribute. Increased bicarbonate secretion in the pancreatic ducts may greatly add to the beneficial effects of melatonin observed in the gastrointestinal tract.
Abbreviations PANC (PANC-1); MIA (MIA PaCa-2); pH i (intracellular pH); MT1 (melatonin receptor 1), MT2 (melatonin receptor 2).
